PHOTO: © Eric Limon / Marijuana company Cann Group has signed a distribution deal to allow approved patients access the company’s drugs at pharmacies around Australia. Symbion, which supplies health care products to 4,000 retail pharmacies and 1,300 hospitals around Australia, will carry Cann’s imported medical cannabis products. The company is looking at importing formulated oils and soft gel caps with a range of cannabinoid profiles, a spokesman said. ARTICLE CONTINUES AFTER THIS ADVERTISEMENT More than 20,000 Australians have been approved to use medical cannabis to treat conditions including cancer pain, chemotherapy-induced vomiting, drug-resistant epilepsy and anorexia under a special program set up in 2016. ASX-listed Althea has also been dispensing medical cannabis through Australian pharmacies while a number of other companies including THC Global are working towards that goal. Cronos Australia, which plans to import medical cannabis grown in Canada by major shareholder Cronos Group, began trading […]